Table 3.
Activity | Type I IFN | Type II IFN | Type III IFN |
---|---|---|---|
IFN-responsive genesa | 2169 | 2339 | 159 |
Inducibility by virus infections | ++++ | +++ | ++ |
Induction of antiviral effectors | ++++ | ++ | ++ |
Cell growth inhibition | ++ | ++++ | + |
Induction of autophagy | ++ | ++ | nsb |
Stimulation/inhibition of cell differentiation | ++ | ++++ | ns |
Stimulation of MHC class I antigens | ++ | ++++ | ++ |
Stimulation of MHC class II antigens | ++ | ++++ | ns |
Stimulation/inhibition of phagocytosis | ++ | ++++ | ns |
Stimulation/inhibition of antibody production | ++ | ++++ | ns |
Inhibition of intracellular parasites | +, indirect | ++, direct | ns |
Induction of IFN, cytokines and chemokines | + | ++ | + |
Induction of neurologic symptoms | ++ | ++ | − |
Specific receptor distribution in the body | Ubiquitous | Ubiquitous | Tissue-restricted |
Cellular genes with p-value <0.05 and fold change ≥2, according to http://www.interferome.org[60].
ns: not studied, so far.